Yoon Hee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoon Hee Kim has a total of 345 co-authors. Here are the top co-authors by number of shared publications:
- Kyung Won Kim
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea
71 shared publications - Myung Hyun Sohn
Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
64 shared publications - In Suk Sol
Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
35 shared publications - Min Jung Kim
Department of Pediatrics, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, Republic of Korea
31 shared publications - Soo Yeon Kim
Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
26 shared publications Kyu-Earn Kim
Sowha Children's Hospital, Seoul, Korea
24 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 525-534
Associations Between Serum Resolvin D1 Levels and Food Allergy Persistence in Children
Park M, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):525-534. https://doi.org/10.4168/aair.2026.18.4.525
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 525-534
Open AccessAssociations Between Serum Resolvin D1 Levels and Food Allergy Persistence in Children
Park M, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):525-534. https://doi.org/10.4168/aair.2026.18.4.525
- Open Access
- 1 January 2026
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 14 (2) , 55-59
Can asthma go away in children? Pro: Yes, it can
김윤희, et al. Allergy Asthma Respir Dis. 2026 Apr;14(2):55-59. https://doi.org/10.4168/aard.2026.14.2.55
- 1 January 2026
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 14 (2) , 55-59
Open AccessCan asthma go away in children? Pro: Yes, it can
김윤희, et al. Allergy Asthma Respir Dis. 2026 Apr;14(2):55-59. https://doi.org/10.4168/aard.2026.14.2.55
- Open Access
- 30 November 2025
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 40 (4) , 605-613
Weight variability at pediatric intensive care unit admission and adverse outcomes in critically ill children
Background: Body weight can fluctuate during critical illness due to factors such as fluid shifts, nutritional status, the type of acute illness, and underlying comorbidities. We investigated the association between acute body weight variability (WV) and clinical outcomes in critically ill pediatric patients.Methods: We retrospectively analyzed data from patients aged 1 month to 18 years who were admitted to the pediatric intensive care unit (PICU) of a university-affiliated tertiary hospital between August 2017 and July 2021. WV was defined as the percentage difference between the measured body weight at PICU admission and the usual body weight, obtained either from recent hospital records or caregiver reports. Associations between WV and clinical outcomes, including PICU mortality and ventilator-free days (VFDs), were assessed.Results: Of the 926 patients, 74 (8.0%) died. Median WV was significantly higher in non-survivors than in survivors (8.7% vs. 0.0%; P<0.001). Increased WV was independently associated with higher mortality (hazard ratio [HR], 1.102; 95% CI, 1.073–1.131) and fewer VFDs (odds ratio [OR], 0.599; 95% CI, 0.524–0.684). Combining WV with Pediatric Index of Mortality 3 score significantly improved mortality prediction over either parameter alone (area under the curve, 0.888; P=0.047).Conclusions: Higher WV at PICU admission is independently associated with adverse clinical outcomes, including increased mortality and fewer VFDs. WV could complement existing mortality prediction models in pediatric critical care.
- 30 November 2025
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 40 (4) , 605-613
Open AccessWeight variability at pediatric intensive care unit admission and adverse outcomes in critically ill children
Background: Body weight can fluctuate during critical illness due to factors such as fluid shifts, nutritional status, the type of acute illness, and underlying comorbidities. We investigated the association between acute body weight variability (WV) and clinical outcomes in critically ill pediatric patients.Methods: We retrospectively analyzed data from patients aged 1 month to 18 years who were admitted to the pediatric intensive care unit (PICU) of a university-affiliated tertiary hospital between August 2017 and July 2021. WV was defined as the percentage difference between the measured body weight at PICU admission and the usual body weight, obtained either from recent hospital records or caregiver reports. Associations between WV and clinical outcomes, including PICU mortality and ventilator-free days (VFDs), were assessed.Results: Of the 926 patients, 74 (8.0%) died. Median WV was significantly higher in non-survivors than in survivors (8.7% vs. 0.0%; P<0.001). Increased WV was independently associated with higher mortality (hazard ratio [HR], 1.102; 95% CI, 1.073–1.131) and fewer VFDs (odds ratio [OR], 0.599; 95% CI, 0.524–0.684). Combining WV with Pediatric Index of Mortality 3 score significantly improved mortality prediction over either parameter alone (area under the curve, 0.888; P=0.047).Conclusions: Higher WV at PICU admission is independently associated with adverse clinical outcomes, including increased mortality and fewer VFDs. WV could complement existing mortality prediction models in pediatric critical care.
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (6) , 787-796
Bronchodilator Response of TEV/FEV3 and Its Implications in Pediatric Asthma
Kim H, et al. Allergy Asthma Immunol Res. 2025 Nov;17(6):787-796. https://doi.org/10.4168/aair.2025.17.6.787
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (6) , 787-796
Open AccessBronchodilator Response of TEV/FEV3 and Its Implications in Pediatric Asthma
Kim H, et al. Allergy Asthma Immunol Res. 2025 Nov;17(6):787-796. https://doi.org/10.4168/aair.2025.17.6.787
- Open Access
- 15 September 2024
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 67 (9) , 418-426
Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents
Noncystic fibrosis bronchiectasis is a chronic respiratory disease that carries high socioeconomic and medical burdens and is caused by diverse respiratory illnesses. To improve clinical outcomes, early recognition, active treatment of exacerbations, and prevention of further exacerbations are essential. However, evidence for the treatment and prevention of acute exacerbation of noncystic fibrosis bronchiectasis, especially in children, is lacking. Therefore, the evidence- and consensus-based guidelines for medical and nonmedical treatment strategies for noncystic fibrosis bronchiectasis in children and adolescents were developed by the Korean Academy of Pediatric Allergy and Respiratory Disease using the methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation working group with evidence published through July 2, 2020. This guideline encompasses evidence-based treatment recommendations as well as expert opinions, addressing crucial aspects of the treatment and management of non-cystic fibrosis bronchiectasis in children. This includes considerations for antibiotics and airway clearance strategies, particularly in areas where evidence may be limited. Large, well-designed, and controlled studies are required to accumulate further evidence of management strategies for noncystic fibrosis bronchiectasis in children and adolescents.
- 15 September 2024
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 67 (9) , 418-426
Open AccessEvidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents
Noncystic fibrosis bronchiectasis is a chronic respiratory disease that carries high socioeconomic and medical burdens and is caused by diverse respiratory illnesses. To improve clinical outcomes, early recognition, active treatment of exacerbations, and prevention of further exacerbations are essential. However, evidence for the treatment and prevention of acute exacerbation of noncystic fibrosis bronchiectasis, especially in children, is lacking. Therefore, the evidence- and consensus-based guidelines for medical and nonmedical treatment strategies for noncystic fibrosis bronchiectasis in children and adolescents were developed by the Korean Academy of Pediatric Allergy and Respiratory Disease using the methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation working group with evidence published through July 2, 2020. This guideline encompasses evidence-based treatment recommendations as well as expert opinions, addressing crucial aspects of the treatment and management of non-cystic fibrosis bronchiectasis in children. This includes considerations for antibiotics and airway clearance strategies, particularly in areas where evidence may be limited. Large, well-designed, and controlled studies are required to accumulate further evidence of management strategies for noncystic fibrosis bronchiectasis in children and adolescents.
- 1 March 2024
- Published by Oceanside Publications Inc. in Allergy and Asthma Proceedings
- Vol. 45 (2) , 112-119
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study
Background: There is a lack of studies about which factors affect the quality of life (QoL) in children with atopic dermatitis (AD), although it is well known that AD has considerably negative effects on their QoL. Objective: This study aimed to measure the QoL in children with AD and identify the factors that affect their QoL. Methods: A questionnaire derived from the Children’s Dermatology Life Quality Index (CDLQI) was used to measure QoL. Family history, allergic comorbidities, exacerbation-related factors, time of exacerbation, and previous and current treatment were also evaluated. The total immunoglobulin E (IgE) level and specific IgE sensitization were determined by the multiple allergen simultaneous test, allergy test, or skin-prick test. AD severity was categorized into mild, moderate, and severe based on treatments. Results: In total, 254 children (46.4 months, 53% boys) from seven hospitals completed the survey. The mean CDLQI score was 7.2 ± 5.5 (total score range of 0‐30). The respondents were divided into three groups according to their QoL score distribution, with 0 − 4 points (n = 84), 5 − 9 points (n = 90), and ≥10 points (n = 80) representing good, fair, and poor QoL, respectively. The more severe AD showed the higher CDLQI score significantly (p = 0.001). Compared with other groups, children with poor QoL were more sensitized to inhalant allergens (odds ratio [OR] 1.29 [95% confidence interval {CI}], 1.03 − 1.62) and had more exacerbating factors (OR 1.26 [95% CI, 1.04 − 1.54]), which included inhalation allergen‐related exacerbating factors (OR 2.54 [95% CI, 1.23 − 5.23), even after adjusting for age, total IgE, body mass index, severity, and use of moisturizer. The concordance between animal sensitization and an exacerbating factor, including dog and cat, was fair, with 0.39 κ and 0.85 accuracy. Conclusion: This study showed that impaired QoL in children with AD is associated with inhalant allergen sensitization and inhalant allergen‐related exacerbation factors. Especially, dog and cat sensitization was a significant exacerbating factor. The inhalation-related exacerbation factors, including animal allergens, might be addressed to improve AD management in children.
- 1 March 2024
- Published by Oceanside Publications Inc. in Allergy and Asthma Proceedings
- Vol. 45 (2) , 112-119
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study
Background: There is a lack of studies about which factors affect the quality of life (QoL) in children with atopic dermatitis (AD), although it is well known that AD has considerably negative effects on their QoL. Objective: This study aimed to measure the QoL in children with AD and identify the factors that affect their QoL. Methods: A questionnaire derived from the Children’s Dermatology Life Quality Index (CDLQI) was used to measure QoL. Family history, allergic comorbidities, exacerbation-related factors, time of exacerbation, and previous and current treatment were also evaluated. The total immunoglobulin E (IgE) level and specific IgE sensitization were determined by the multiple allergen simultaneous test, allergy test, or skin-prick test. AD severity was categorized into mild, moderate, and severe based on treatments. Results: In total, 254 children (46.4 months, 53% boys) from seven hospitals completed the survey. The mean CDLQI score was 7.2 ± 5.5 (total score range of 0‐30). The respondents were divided into three groups according to their QoL score distribution, with 0 − 4 points (n = 84), 5 − 9 points (n = 90), and ≥10 points (n = 80) representing good, fair, and poor QoL, respectively. The more severe AD showed the higher CDLQI score significantly (p = 0.001). Compared with other groups, children with poor QoL were more sensitized to inhalant allergens (odds ratio [OR] 1.29 [95% confidence interval {CI}], 1.03 − 1.62) and had more exacerbating factors (OR 1.26 [95% CI, 1.04 − 1.54]), which included inhalation allergen‐related exacerbating factors (OR 2.54 [95% CI, 1.23 − 5.23), even after adjusting for age, total IgE, body mass index, severity, and use of moisturizer. The concordance between animal sensitization and an exacerbating factor, including dog and cat, was fair, with 0.39 κ and 0.85 accuracy. Conclusion: This study showed that impaired QoL in children with AD is associated with inhalant allergen sensitization and inhalant allergen‐related exacerbation factors. Especially, dog and cat sensitization was a significant exacerbating factor. The inhalation-related exacerbation factors, including animal allergens, might be addressed to improve AD management in children.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (5) , 555-561
Diagnostic Decision Point for IgE-Mediated Wheat Allergy in Children
Hwang Y, et al. Allergy Asthma Immunol Res. 2024 Sep;16(5):555-561. https://doi.org/10.4168/aair.2024.16.5.555
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (5) , 555-561
Open AccessDiagnostic Decision Point for IgE-Mediated Wheat Allergy in Children
Hwang Y, et al. Allergy Asthma Immunol Res. 2024 Sep;16(5):555-561. https://doi.org/10.4168/aair.2024.16.5.555
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (2) , 179-190
Predicting the Outcome of Pediatric Oral Food Challenges for Determining Tolerance Development
Kim H, et al. Allergy Asthma Immunol Res. 2024 Mar;16(2):179-190. https://doi.org/10.4168/aair.2024.16.2.179
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (2) , 179-190
Open AccessPredicting the Outcome of Pediatric Oral Food Challenges for Determining Tolerance Development
Kim H, et al. Allergy Asthma Immunol Res. 2024 Mar;16(2):179-190. https://doi.org/10.4168/aair.2024.16.2.179
- Open Access
- 15 February 2023
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 66 (2) , 85-87
Role of serum bilirubin-to-albumin ratio as a prognostic index in critically ill children
- 15 February 2023
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 66 (2) , 85-87
Open AccessRole of serum bilirubin-to-albumin ratio as a prognostic index in critically ill children
- Open Access
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (6) , 384-394
Radiologic Assessment of Lung Edema Score as a Predictor of Clinical Outcome in Children with Acute Respiratory Distress Syndrome
Han CH, et al. Yonsei Med J. 2023 Jun;64(6):384-394. https://doi.org/10.3349/ymj.2022.0653
- 1 January 2023
- Published by XMLink in Yonsei Medical Journal
- Vol. 64 (6) , 384-394
Open AccessRadiologic Assessment of Lung Edema Score as a Predictor of Clinical Outcome in Children with Acute Respiratory Distress Syndrome
Han CH, et al. Yonsei Med J. 2023 Jun;64(6):384-394. https://doi.org/10.3349/ymj.2022.0653